Fundraising Fox
Adipo Therapeutics
Indianapolis, US · Founded 2016 · Indiana LLC · 6 known investors
Find your way into Adipo Therapeutics
Each arrow is one introduction. Sign up to fill in the first one.
Ask Samuel Levy to introduce you to Keith Johns
You →Samuel · together at Allurion →Keith
Ask Jamie Chen to introduce you to Karen Wurster
You →Jamie · together at Lilly Asia Ventures →Karen
Sign up to find every way you can get introduced to Adipo Therapeutics
- Your email: who you already know at Adipo Therapeutics, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Adipo Therapeutics team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Adipo develops investigational therapeutics that promote weight loss by activating brown fat to increase energy expenditure, offering an alternative to appetite-suppressing drugs like GLP-1s. The company targets people seeking weight management solutions beyond diet and calorie restriction.
Founders & leadership
Board
Investors · 6
How we know: insideindianabusiness.com · the VCSheet dataset · Not right? Tell us
Also in the syndicate · 2
Funding
SEC filings, press & company announcements$6M disclosed across 2 of 3 rounds · 2020–2024
- Undisclosed amountbridge funding roundJan 2024
Elevate Ventures, IU Ventures, Purdue Research Foundation, VisionTech Partners
Source ↗
▶$4.7MraisedDec 2024 · 20 investors · BiotechnologyRule 506(b)
- Keith JohnsExecutive Officer
- Karen WursterExecutive Officer, Director
- Meng DengDirector
- Michael ClaymanDirector
- Offering amount
- $14.7M
- Amount sold
- $4.7M
- Proceeds to insiders
- $219.1K
- First sale
- Nov 2024
- Incorporated
- Limited Liability Company, Indiana
- Federal exemptions
- 06b
▶$1.3MraisedSep 2020 · 2 investors · BiotechnologyRule 506(b)
- Meng DengExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $1.3M
- First sale
- Aug 2020
- Incorporated
- Limited Liability Company, Indiana, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
Companies working in the same space as Adipo Therapeutics.
Frequently asked questions
- What does Adipo Therapeutics do?
- Adipo develops investigational therapeutics that promote weight loss by activating brown fat to increase energy expenditure, offering an alternative to appetite-suppressing drugs like GLP-1s. The company targets people seeking weight management solutions beyond diet and calorie restriction.
- Who are Adipo Therapeutics's investors?
- Adipo Therapeutics's investors include Elevate Ventures, IU Ventures, Okeanos, Riverbend Capital.
- How much funding has Adipo Therapeutics raised?
- Adipo Therapeutics has disclosed $6M raised across 2 of its 3 known rounds.
- Where is Adipo Therapeutics headquartered?
- Adipo Therapeutics is headquartered in Indianapolis, US.